Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson's disease.

Neuroscience letters - 30 Jan 2004

Wang Jian, Zhao Chunying, Chen Biao, Liu Zhuo-Lin

Abstract excerpt

The authors conducted a case-control study of Parkinson's disease patients with and without visual hallucinations to investigate associations of the polymorphisms of the dopamine receptors D2 32806 C>T (Taq1A), D3 Ser9Gly and Msp1, D5 978T>C and dopamine transporter 3'-UTR 40 bp VNTR with visual hallucinations in Parkinson's disease. No significant differences were found between hallucinators and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chi-Square Distribution
Share to Dopamine Plasma Membrane Transport Proteins

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hallucinations

Share to Membrane Glycoproteins

Share to Membrane Transport Proteins

Share to Parkinson Disease

Share to Receptors, Dopamine

Share to Statistics, Nonparametric

Source

Identifiers

PMID: 14732464
DOI: 10.1016/j.neulet.2003.11.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Polymorphisms of dopamine receptor and transporter genes and hallucinations in Parkinson's disease.PMID 14732464Read ↗

Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson's patients.Semantic proximity Read ↗

Visual hallucinations in Parkinson's disease are not influenced by polymorphisms of serotonin 5-HT2A receptor and transporter genes.Semantic proximity Read ↗

Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study.Semantic proximity Read ↗

Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's disease.Semantic proximity Read ↗

Polymorphisms in candidate genes: implications for the current treatment of Parkinson's disease.Semantic proximity Read ↗

Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system.Semantic proximity Read ↗

Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's DiseaseSemantic proximity Read ↗

No association of COMT val158met polymorphism and psychotic symptoms in Lewy body dementias.Semantic proximity Read ↗

Serotonin and dopamine transporter genes do not influence depression in Parkinson's disease.Semantic proximity Read ↗

No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms.Semantic proximity Read ↗

Polymorphisms of dopamine receptor and transporter genes and Parkinson's disease.Semantic proximity Read ↗

Case‐Control study of dopamine transporter‐1, monoamine oxidase‐B, and catechol‐<i>O</i>‐methyl transferase polymorphisms in Parkinson's diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.